Xeris Biopharma Holdings, Inc.
(XERS - NASDAQ)
6,12 USD
📋 Profilo Aziendale

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology.

|